Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2015 Jun 12;29024:15292-303. doi: 10.1074/jbc.M114.611178.
Show Gene links
Show Anatomy links
Critical Roles of Two Hydrophobic Residues within Human Glucose Transporter 9 (hSLC2A9) in Substrate Selectivity and Urate Transport.
Long W
,
Panwar P
,
Witkowska K
,
Wong K
,
O'Neill D
,
Chen XZ
,
Lemieux MJ
,
Cheeseman CI
.
???displayArticle.abstract???
High blood urate levels (hyperuricemia) have been found to be a significant risk factor for cardiovascular diseases and inflammatory arthritis, such as hypertension and gout. Human glucose transporter 9 (hSLC2A9) is an essential protein that mainly regulates urate/hexose homeostasis in human kidney and liver. hSLC2A9 is a high affinity-low capacity hexose transporter and a high capacity urate transporter. Our previous studies identified a single hydrophobic residue in trans-membrane domain 7 of class II glucose transporters as a determinant of fructose transport. A mutation of isoleucine 335 to valine (I355V) in hSLC2A9 can reduce fructose transport while not affecting glucose fluxes. This current study demonstrates that the I335V mutant transports urate similarly to the wild type hSLC2A9; however, Ile-335 is necessary for urate/fructose trans-acceleration exchange to occur. Furthermore, Trp-110 is a critical site for urate transport. Two structural models of the class II glucose transporters, hSLC2A9 and hSLC2A5, based on the crystal structure of hSLC2A1 (GLUT1), reveal that Ile-335 (or the homologous Ile-296 in hSLC2A5) is a key component for protein conformational changes when the protein translocates substrates. The hSLC2A9 model also predicted that Trp-110 is a crucial site that could directly interact with urate during transport. Together, these studies confirm that hSLC2A9 transports both urate and fructose, but it interacts with them in different ways. Therefore, this study advances our understanding of how hSLC2A9 mediates urate and fructose transport, providing further information for developing pharmacological agents to treat hyperuricemia and related diseases, such as gout, hypertension, and diabetes.
Abramson,
Structure and mechanism of the lactose permease of Escherichia coli.
2003, Pubmed
Abramson,
Structure and mechanism of the lactose permease of Escherichia coli.
2003,
Pubmed
Augustin,
The protein family of glucose transport facilitators: It's not only about glucose after all.
2010,
Pubmed
Bibert,
Mouse GLUT9: evidences for a urate uniporter.
2009,
Pubmed
,
Xenbase
Bo,
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes.
2001,
Pubmed
Cannon,
Hyperuricemia in primary and renal hypertension.
1966,
Pubmed
Carruthers,
Will the original glucose transporter isoform please stand up!
2009,
Pubmed
Caulfield,
SLC2A9 is a high-capacity urate transporter in humans.
2008,
Pubmed
,
Xenbase
Cheeseman,
Solute carrier family 2, member 9 and uric acid homeostasis.
2009,
Pubmed
,
Xenbase
Cura,
Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.
2012,
Pubmed
Deng,
Crystal structure of the human glucose transporter GLUT1.
2014,
Pubmed
Dietvorst,
Amino acid residues involved in ligand preference of the Snf3 transporter-like sensor in Saccharomyces cerevisiae.
2010,
Pubmed
Emmerson,
Effect of oral fructose on urate production.
1974,
Pubmed
Faham,
The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport.
2008,
Pubmed
Hill,
Isolation and characterization of the Xenopus oocyte plasma membrane: a new method for studying activity of water and solute transporters.
2005,
Pubmed
,
Xenbase
Hirai,
Structural model for 12-helix transporters belonging to the major facilitator superfamily.
2003,
Pubmed
Huang,
Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli.
2003,
Pubmed
Iancu,
Crystal structure of a glucose/H+ symporter and its mechanism of action.
2013,
Pubmed
Jayaraj,
Role of large hydrophobic residues in proteins.
2009,
Pubmed
Johnson,
The effect of fructose on renal biology and disease.
2010,
Pubmed
Johnson,
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
2003,
Pubmed
Joost,
The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review).
2001,
Pubmed
Katagiri,
Role of tryptophan-388 of GLUT1 glucose transporter in glucose-transport activity and photoaffinity-labelling with forskolin.
1993,
Pubmed
Katagiri,
Substitution of leucine for tryptophan 412 does not abolish cytochalasin B labeling but markedly decreases the intrinsic activity of GLUT1 glucose transporter.
1991,
Pubmed
Kayano,
Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6).
1990,
Pubmed
,
Xenbase
Kimura,
Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells.
2014,
Pubmed
Komala,
Sodium glucose cotransporter 2 and the diabetic kidney.
2013,
Pubmed
Komoda,
The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia.
2004,
Pubmed
Krishnamurthy,
Unlocking the molecular secrets of sodium-coupled transporters.
2009,
Pubmed
Madej,
Functional architecture of MFS D-glucose transporters.
2014,
Pubmed
Maher,
Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons.
1996,
Pubmed
Manolescu,
A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity.
2007,
Pubmed
,
Xenbase
Manolescu,
Identification of a hydrophobic residue as a key determinant of fructose transport by the facilitative hexose transporter SLC2A7 (GLUT7).
2005,
Pubmed
,
Xenbase
Matsuo,
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.
2008,
Pubmed
Mueckler,
Identification of an amino acid residue that lies between the exofacial vestibule and exofacial substrate-binding site of the Glut1 sugar permeation pathway.
1997,
Pubmed
,
Xenbase
Mueckler,
The SLC2 (GLUT) family of membrane transporters.
2013,
Pubmed
Onat,
Serum uric acid is a determinant of metabolic syndrome in a population-based study.
2006,
Pubmed
Phay,
Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9).
2000,
Pubmed
Puig,
Uric acid as a cardiovascular risk factor in arterial hypertension.
1999,
Pubmed
Robert,
Deciphering key features in protein structures with the new ENDscript server.
2014,
Pubmed
Salas-Burgos,
Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules.
2004,
Pubmed
Seatter,
QLS motif in transmembrane helix VII of the glucose transporter family interacts with the C-1 position of D-glucose and is involved in substrate selection at the exofacial binding site.
1998,
Pubmed
,
Xenbase
Sievers,
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.
2011,
Pubmed
Smirnova,
Lactose permease and the alternating access mechanism.
2011,
Pubmed
Stein,
The mechanism of sugar transfer across erythrocyte membranes.
1972,
Pubmed
Sun,
Crystal structure of a bacterial homologue of glucose transporters GLUT1-4.
2012,
Pubmed
Sweet,
Are there kinetic advantages of GLUT2 in pancreatic glucose sensing?
1997,
Pubmed
Taylor,
Symmetrical kinetic parameters for 3-O-methyl-D-glucose transport in adipocytes in the presence and in the absence of insulin.
1981,
Pubmed
Vollers,
Sequence determinants of GLUT1-mediated accelerated-exchange transport: analysis by homology-scanning mutagenesis.
2012,
Pubmed
WIDDAS,
Inability of diffusion to account for placental glucose transfer in the sheep and consideration of the kinetics of a possible carrier transfer.
1952,
Pubmed
Wang,
Filamin interacts with epithelial sodium channel and inhibits its channel function.
2013,
Pubmed
,
Xenbase
Witkowska,
Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.
2012,
Pubmed
,
Xenbase
Zhang,
I-TASSER server for protein 3D structure prediction.
2008,
Pubmed
